Article PDF
References
Davis AR, Diggory P, Seward HC . Prevalence of chronic hypokalaemia amongst elderly patients using acetazolamide and diuretics. Eye 1995;9:381–2.
Reid W, Harrower ADB . Acetazolamide and symptomatic metabolic acidosis in mild renal failure. BMJ 1982;284:1114.
Parker WA, Atkinson B . Acetazolamide therapy and acid-base disturbance. Can J Hosp Pharm 1987;40:31–4.
Maisey DN, Brown RD . Acetazolamide and symptomatic metabolic acidosis in mild renal failure. BMJ 1981;283:1527–8.
Everitt D, Avorn J . Systemic effects of medications used to treat glaucoma. Ann Intern Med 1990;112:120–5.
Heller I, Harvey J, Cohen S, Theodar E . Significant metabolic acidosis induced by acetazolamide: not a rare complication. Arch Intern Med 1985;145:1815–7.
Arrigg CA, Epstein DL, Glovanoni R, Grant WM . The influence of supplemental sodium acetate on carbonic anhydrase inhibitor-induced side affects. Arch Ophthalmol 1981;99:1969–72.
Sweeney KR, Chapron DJ, Leonard Bradt J, et al. Toxic interaction between acetazolamide and salicylate: case report and a pharmacokinetic explanation. Clin Pharmacol Ther 1986;40:518–24.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barnes, E., Reynolds, A., Rauz, S. et al. Letter. Eye 10, 648 (1996). https://doi.org/10.1038/eye.1996.151
Issue Date:
DOI: https://doi.org/10.1038/eye.1996.151
This article is cited by
-
Laborkontrollen in der Pharmakotherapie der Epilepsien
Zeitschrift für Epileptologie (2011)